MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/00365521.2026.2642822

Медицинская библиотека · Scandinavian journal of gastroenterology · 2026

Real-world management of intraductal papillary mucinous neoplasms - findings from a nationwide survey.

Andersson Bodil, Ghorbani Poya, Öman Mikael, Björnsson Bergthor, Wennerblom Hansson Johanna, Szepesvari Robert, Al-Jubouri Muhammed, Nilsson Johan, Williamsson Caroline

СтатьяПеревод в очереди

Аннотация

BACKGROUND/

OBJECTIVES

A nationwide survey, covering all surgical departments, was conducted in a country with easily accessible tax-funded healthcare. The survey aimed to provide insight into 'real-world' intraductal papillary mucinous neoplasia (IPMN) surveillance, including the proportion of patients monitored, adherence to guidelines and details of follow-up.

METHODS

At all hospitals caring for IPMN patients in Sweden (n = 46), an upper-gastrointestinal surgeon received a survey by mail with clinically oriented questions, including a mix of Likert scale, multiple-choice and open-ended questions. Up to three reminders were sent.

RESULTS

Forty-five hospitals responded. In median 116 (10-1500) patients with IPMN were followed at each hospital. At the hospital with the largest volume 14 physicians were involved in IPMN surveillance. In 9/45 hospitals, other professionals, such as registered nurses and secretaries, were actively involved in surveillance. All hospitals were aware of the national care program for IPMN, and all but three adhered to it. Nevertheless, uncertainty persisted about whether resources are being used wisely in branch duct (BD)-IPMN surveillance (yes/no/unsure; university hospital 2/4/0, county hospital 0/20/3 and district hospital 3/7/1). Comorbidity, older age, patient's own decision, and a combination of age and stable radiological findings were reasons for ending surveillance. Twenty-eight of 45 responders believed that surveillance will be changed in 5 years and almost all, 42/45 in 10 years.

CONCLUSIONS

Adherence to the national care program for IPMN was very good, although a majority questioned the current follow-up of BD-IPMN from a resource perspective. There is a strong belief that new knowledge will change the guidelines in the near future.

Для цитирования: Andersson Bodil, Ghorbani Poya, Öman Mikael, Björnsson Bergthor, Wennerblom Hansson Johanna, Szepesvari Robert, Al-Jubouri Muhammed, Nilsson Johan, Williamsson Caroline. Real-world management of intraductal papillary mucinous neoplasms - findings from a nationwide survey.. Scandinavian journal of gastroenterology. 2026. DOI: 10.1080/00365521.2026.2642822.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.